NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

But yet NWBO hasn't filed an application for MHRA approval required for commercial sale.

61 months since this PR

“Now that the data from our Phase 3 clinical trial of DCVax®-L have further matured and provided a further encouraging picture of patient survival, and we are ready to move forward with the months of work related to completion of the trial, we are very pleased to have a new war chest of funding for this work,” commented Linda Powers, CEO of NW Bio. “We are also looking forward to proceeding with further DCVax®-Direct trials.”